Serum microRNA-204 levels are associated with long-term cardiovascular disease risk based on the Framingham risk score in patients with type 2 diabetes:results from an observational study

Rui WANG; Yao-Dong DING; Wen GAO; Yu-Qiang PEI; Jia-Xin YANG; Ying-Xin ZHAO; Xiao-Li LIU; Hua SHEN; Shuo ZHANG; Lei YU; Hai-Long GE

doi:10.11909/j.issn.1671-5411.2020.06.006

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Serum microRNA-204 levels are associated with long-term cardiovascular disease risk based on the Framingham risk score in patients with type 2 diabetes:results from an observational study

DOI: 10.11909/j.issn.1671-5411.2020.06.006

Serum microRNA-204 levels are associated with long-term cardiovascular disease risk based on the Framingham risk score in patients with type 2 diabetes:results from an observational study

Rui WANG

Yao-Dong DING

Wen GAO

Yu-Qiang PEI

Jia-Xin YANG

Ying-Xin ZHAO

Xiao-Li LIU

Hua SHEN

Shuo ZHANG

Lei YU

Hai-Long GE

Keywords：Cardiovascular diseaseFramingham risk scoreMicroRNA-204Type 2 diabetes mellitus

Publication Date：2020-06-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 330-337 )

Journal of Geriatric Cardiology

SCICSCD

ISSN：1671-5411

Year, Vol.(Issue)：2020,17(6)